Objectives: 1. The periorbital area – anatomy, histology, and aging pathogenesis.
2. Tixel mechanism of action (thermal mechanical fractional injury = TMFI) and advantages
3. Neocollagenesis and drug delivery - Comparison of EBDs.

Introduction: The periorbital region, comprising the delicate skin surrounding the eyes, is particularly prone to showing signs of aging, including fine lines, wrinkles, puffiness, and dark circles.

Many patients seek for non-invasive alternatives, that offer less downtime and minimal risk, and yet are effective. Among these, Tixel is safe and promising treatment modality for this area, offering optimal neocollagenesis and drug delivery.

Materials / method: A literature review was conducted to compare different EBDs usage in the periorbital area. This knowledge was combined with my practical experience with many energy based devices, including the Tixel.

Results: The periorbital area, surrounding the eyes, is a complex anatomical region, comprising multiple layers, including skin, subcutaneous fat, muscles, and underlying bony structures, its histology reflects its multifaceted function. The skin in this area is among the thinnest on the body, making it prone to visible signs of aging.

The Tixel can be applied safely into this region, heating the skin uniformly and open micro-channels for the delivery of essential active ingredients that synergistically improve periorbital rejuvenation potential.

Conclusion: The Tixel is optimal for periorbital area treatments, allowing individualization of the treatment and addressing all the pathologies associate with skin aging including wrinkles, texture, hyperpigmentation and skin laxity.

Declaraciones

¿Ha recibido algún tipo de financiamiento para realizar su investigación sobre esta temática?
No

¿Ha recibido algún pago, honorario u otra compensación por su trabajo acerca de esta investigación?
Si
Por favor especifique las entidades (individuo, empresa, sociedad): Novoxel company (Tixel)

¿Tiene vínculos financieros con alguna entidad que podría llegar a competir estrechamente con los medicamentos, materiales o instrumentos tratados en su investigación?
No

¿Posee o ha solicitado una patente relacionada a los materiales, productos o instrumentos utilizados en su investigación?
No

Este trabajo es presentado gracias al apoyo de: Novoxel company (Tixel)